IBDEI2FD ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,38740,1,3,0)
;;=3^Heart Failure,Diastolic,Chronic
;;^UTILITY(U,$J,358.3,38740,1,4,0)
;;=4^I50.32
;;^UTILITY(U,$J,358.3,38740,2)
;;=^5007245
;;^UTILITY(U,$J,358.3,38741,0)
;;=I50.42^^152^1985^36
;;^UTILITY(U,$J,358.3,38741,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38741,1,3,0)
;;=3^Heart Failure,Systolic & Diastolic,Chronic
;;^UTILITY(U,$J,358.3,38741,1,4,0)
;;=4^I50.42
;;^UTILITY(U,$J,358.3,38741,2)
;;=^5007249
;;^UTILITY(U,$J,358.3,38742,0)
;;=I13.0^^152^1985^30
;;^UTILITY(U,$J,358.3,38742,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38742,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,38742,1,4,0)
;;=4^I13.0
;;^UTILITY(U,$J,358.3,38742,2)
;;=^5007067
;;^UTILITY(U,$J,358.3,38743,0)
;;=I13.2^^152^1985^31
;;^UTILITY(U,$J,358.3,38743,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38743,1,3,0)
;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,38743,1,4,0)
;;=4^I13.2
;;^UTILITY(U,$J,358.3,38743,2)
;;=^5007070
;;^UTILITY(U,$J,358.3,38744,0)
;;=I13.10^^152^1985^32
;;^UTILITY(U,$J,358.3,38744,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38744,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
;;^UTILITY(U,$J,358.3,38744,1,4,0)
;;=4^I13.10
;;^UTILITY(U,$J,358.3,38744,2)
;;=^5007068
;;^UTILITY(U,$J,358.3,38745,0)
;;=I13.11^^152^1985^33
;;^UTILITY(U,$J,358.3,38745,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38745,1,3,0)
;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
;;^UTILITY(U,$J,358.3,38745,1,4,0)
;;=4^I13.11
;;^UTILITY(U,$J,358.3,38745,2)
;;=^5007069
;;^UTILITY(U,$J,358.3,38746,0)
;;=E03.9^^152^1985^43
;;^UTILITY(U,$J,358.3,38746,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38746,1,3,0)
;;=3^Hypothyroidism,Unspec
;;^UTILITY(U,$J,358.3,38746,1,4,0)
;;=4^E03.9
;;^UTILITY(U,$J,358.3,38746,2)
;;=^5002476
;;^UTILITY(U,$J,358.3,38747,0)
;;=M54.5^^152^1985^46
;;^UTILITY(U,$J,358.3,38747,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38747,1,3,0)
;;=3^Low Back Pain
;;^UTILITY(U,$J,358.3,38747,1,4,0)
;;=4^M54.5
;;^UTILITY(U,$J,358.3,38747,2)
;;=^5012311
;;^UTILITY(U,$J,358.3,38748,0)
;;=C61.^^152^1985^47
;;^UTILITY(U,$J,358.3,38748,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38748,1,3,0)
;;=3^Malig Neopl Prostate
;;^UTILITY(U,$J,358.3,38748,1,4,0)
;;=4^C61.
;;^UTILITY(U,$J,358.3,38748,2)
;;=^267239
;;^UTILITY(U,$J,358.3,38749,0)
;;=F11.20^^152^1985^53
;;^UTILITY(U,$J,358.3,38749,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38749,1,3,0)
;;=3^Opioid Dependence,Uncomplicated
;;^UTILITY(U,$J,358.3,38749,1,4,0)
;;=4^F11.20
;;^UTILITY(U,$J,358.3,38749,2)
;;=^5003127
;;^UTILITY(U,$J,358.3,38750,0)
;;=M19.90^^152^1985^54
;;^UTILITY(U,$J,358.3,38750,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38750,1,3,0)
;;=3^Osteoarthritis,Unspec
;;^UTILITY(U,$J,358.3,38750,1,4,0)
;;=4^M19.90
;;^UTILITY(U,$J,358.3,38750,2)
;;=^5010853
;;^UTILITY(U,$J,358.3,38751,0)
;;=M85.80^^152^1985^55
;;^UTILITY(U,$J,358.3,38751,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38751,1,3,0)
;;=3^Osteopenia,Unspec Site
;;^UTILITY(U,$J,358.3,38751,1,4,0)
;;=4^M85.80
;;^UTILITY(U,$J,358.3,38751,2)
;;=^5014473
;;^UTILITY(U,$J,358.3,38752,0)
;;=M81.0^^152^1985^56
;;^UTILITY(U,$J,358.3,38752,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38752,1,3,0)
;;=3^Osteoporosis,Age-Related w/o Fx
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2FD 3765 printed Dec 13, 2024@02:27:39 Page 2
IBDEI2FD ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,38740,1,3,0)
+2 ;;=3^Heart Failure,Diastolic,Chronic
+3 ;;^UTILITY(U,$J,358.3,38740,1,4,0)
+4 ;;=4^I50.32
+5 ;;^UTILITY(U,$J,358.3,38740,2)
+6 ;;=^5007245
+7 ;;^UTILITY(U,$J,358.3,38741,0)
+8 ;;=I50.42^^152^1985^36
+9 ;;^UTILITY(U,$J,358.3,38741,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,38741,1,3,0)
+12 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
+13 ;;^UTILITY(U,$J,358.3,38741,1,4,0)
+14 ;;=4^I50.42
+15 ;;^UTILITY(U,$J,358.3,38741,2)
+16 ;;=^5007249
+17 ;;^UTILITY(U,$J,358.3,38742,0)
+18 ;;=I13.0^^152^1985^30
+19 ;;^UTILITY(U,$J,358.3,38742,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,38742,1,3,0)
+22 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
+23 ;;^UTILITY(U,$J,358.3,38742,1,4,0)
+24 ;;=4^I13.0
+25 ;;^UTILITY(U,$J,358.3,38742,2)
+26 ;;=^5007067
+27 ;;^UTILITY(U,$J,358.3,38743,0)
+28 ;;=I13.2^^152^1985^31
+29 ;;^UTILITY(U,$J,358.3,38743,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,38743,1,3,0)
+32 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
+33 ;;^UTILITY(U,$J,358.3,38743,1,4,0)
+34 ;;=4^I13.2
+35 ;;^UTILITY(U,$J,358.3,38743,2)
+36 ;;=^5007070
+37 ;;^UTILITY(U,$J,358.3,38744,0)
+38 ;;=I13.10^^152^1985^32
+39 ;;^UTILITY(U,$J,358.3,38744,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,38744,1,3,0)
+42 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
+43 ;;^UTILITY(U,$J,358.3,38744,1,4,0)
+44 ;;=4^I13.10
+45 ;;^UTILITY(U,$J,358.3,38744,2)
+46 ;;=^5007068
+47 ;;^UTILITY(U,$J,358.3,38745,0)
+48 ;;=I13.11^^152^1985^33
+49 ;;^UTILITY(U,$J,358.3,38745,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,38745,1,3,0)
+52 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
+53 ;;^UTILITY(U,$J,358.3,38745,1,4,0)
+54 ;;=4^I13.11
+55 ;;^UTILITY(U,$J,358.3,38745,2)
+56 ;;=^5007069
+57 ;;^UTILITY(U,$J,358.3,38746,0)
+58 ;;=E03.9^^152^1985^43
+59 ;;^UTILITY(U,$J,358.3,38746,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,38746,1,3,0)
+62 ;;=3^Hypothyroidism,Unspec
+63 ;;^UTILITY(U,$J,358.3,38746,1,4,0)
+64 ;;=4^E03.9
+65 ;;^UTILITY(U,$J,358.3,38746,2)
+66 ;;=^5002476
+67 ;;^UTILITY(U,$J,358.3,38747,0)
+68 ;;=M54.5^^152^1985^46
+69 ;;^UTILITY(U,$J,358.3,38747,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,38747,1,3,0)
+72 ;;=3^Low Back Pain
+73 ;;^UTILITY(U,$J,358.3,38747,1,4,0)
+74 ;;=4^M54.5
+75 ;;^UTILITY(U,$J,358.3,38747,2)
+76 ;;=^5012311
+77 ;;^UTILITY(U,$J,358.3,38748,0)
+78 ;;=C61.^^152^1985^47
+79 ;;^UTILITY(U,$J,358.3,38748,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,38748,1,3,0)
+82 ;;=3^Malig Neopl Prostate
+83 ;;^UTILITY(U,$J,358.3,38748,1,4,0)
+84 ;;=4^C61.
+85 ;;^UTILITY(U,$J,358.3,38748,2)
+86 ;;=^267239
+87 ;;^UTILITY(U,$J,358.3,38749,0)
+88 ;;=F11.20^^152^1985^53
+89 ;;^UTILITY(U,$J,358.3,38749,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,38749,1,3,0)
+92 ;;=3^Opioid Dependence,Uncomplicated
+93 ;;^UTILITY(U,$J,358.3,38749,1,4,0)
+94 ;;=4^F11.20
+95 ;;^UTILITY(U,$J,358.3,38749,2)
+96 ;;=^5003127
+97 ;;^UTILITY(U,$J,358.3,38750,0)
+98 ;;=M19.90^^152^1985^54
+99 ;;^UTILITY(U,$J,358.3,38750,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,38750,1,3,0)
+102 ;;=3^Osteoarthritis,Unspec
+103 ;;^UTILITY(U,$J,358.3,38750,1,4,0)
+104 ;;=4^M19.90
+105 ;;^UTILITY(U,$J,358.3,38750,2)
+106 ;;=^5010853
+107 ;;^UTILITY(U,$J,358.3,38751,0)
+108 ;;=M85.80^^152^1985^55
+109 ;;^UTILITY(U,$J,358.3,38751,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,38751,1,3,0)
+112 ;;=3^Osteopenia,Unspec Site
+113 ;;^UTILITY(U,$J,358.3,38751,1,4,0)
+114 ;;=4^M85.80
+115 ;;^UTILITY(U,$J,358.3,38751,2)
+116 ;;=^5014473
+117 ;;^UTILITY(U,$J,358.3,38752,0)
+118 ;;=M81.0^^152^1985^56
+119 ;;^UTILITY(U,$J,358.3,38752,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,38752,1,3,0)
+122 ;;=3^Osteoporosis,Age-Related w/o Fx
